Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.50 USD
Change Today -0.115 / -2.49%
Volume 48.9K
ADMP On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 11:10 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David J. Marguglio

Senior Vice President of Corporate Development and Director, Adamis Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 1 different industries.

See Board Relationships
44$401,090
As of Fiscal Year 2014

Background*

Mr. David J. Marguglio serves as a Senior Vice President of Corporate Development at Adamis Pharmaceuticals Corporation. Mr. Marguglio joined Adamis Pharmaceuticals Corporation as Vice President of Business Development and Investor Relations in April 2009 in connection with the closing of the merger transaction between Cellegy and Old Adamis. Mr. Marguglio was a co-founder of Old Adamis and served as its Vice President of Business Development and Investor Relations since ...

Read Full Background

Corporate Headquarters*

11682 El Camino Real
San Diego, California 92130

United States

Phone: 858-997-2400
Fax: --

Board Members Memberships*

2009-N/A
Former Vice President of Business Development & Investor Relations and Director
2009-Present
Senior Vice President of Corporate Development and Director

Education*

Unknown/Other Education
Hankamer School of Business

Other Affiliations*

Annual Compensation*

Salary$197,250
Bonus$65,000
Total Annual Compensation$262,250

Stock Options*

All Other Compensation$13,636
Exercisable Options74,240
Total Number of Options74,240

Total Compensation*

Total Annual Cash Compensation$275,886
Total Short Term Compensation$262,250
Other Long Term Compensation$13,636
Total Calculated Compensation$401,090
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADMP:US $4.50 USD -0.115

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jennifer K. Simpson Ph.D., M.S.N., C.R.N.P.Interim Chief Executive Officer, Interim President, Executive Vice President and Global Head of Business Operations
Delcath Systems, Inc.
$309.6K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADAMIS PHARMACEUTICALS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.